Systematic review reveals that preventive neuroprotective interventions may enhance cognitive outcomes in breast cancer survivors during chemotherapy.
Background Chemotherapy-related cognitive impairment (CRCI) is common among breast cancer survivors (BCS). While numerous rehabilitation interventions exist, these typically occur post-CRCI. Preventive neuroprotective interventions during chemotherapy may improve cognitive outcomes.
No takes yet. Share an insight, caveat, or question.
Shelton et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: